The Importance Of The Starting Materials And Donor Cells

Most cell therapies today are produced from a single patient at a time, using that patient cells as the starting material; yet the one-dose-at-a-time approach can be difficult in a myriad of ways. However, donor cells have their own set of challenges. Blackton and Lee talk through the specific roadblocks for autologous when it comes to both starting materials and allogeneic and donor cells.